Spectral Metafiction as Différance of Authoritative Narrative in Alias Grace
International Journal of English Literature and Social Sciences · 2026 · 11 (6) · 149-160
DOI: 10.22161/ijels.116.20 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of English Literature and Social Sciences, 2026. Verfasst von Mingying Xu und 1 weiteren Autor:innen.
Abstract (Originalsprache)
This paper treats Margaret Atwood’s Alias Grace as a spectral metafictional rewriting to a historic case, examining how Atwood articulates her deconstructive understanding of historic and narrative truth. First, this paper explores how the novel deconstructs the absolute truth sustained by logocentric institutional authorities - namely science, law and religion - exposing the illusion of epistemological certainty. Next, it explore how Grace employs a possessive and spectral voice through death, possession, and defamiliarization to launch a tactful resistance against institutional dominance. Finally, this paper demonstrates how the formal realization of self-reflexive and intertextual narration constitutes a mode of spectral metafiction, wherein the continuous deferral of truth exemplifies Derrida’s concept of différance and ultimately results in spectralization of narrative subjectivity.
Zitieren
APA
Xu, M., & Zhang, W. (2026). Spectral Metafiction as Différance of Authoritative Narrative in Alias Grace. International Journal of English Literature and Social Sciences, 11(6), 149-160. https://doi.org/10.22161/ijels.116.20
Vancouver
Xu M, Zhang W. Spectral Metafiction as Différance of Authoritative Narrative in Alias Grace. International Journal of English Literature and Social Sciences. 2026;11(6):149-160. doi:10.22161/ijels.116.20
BibTeX
@article{Xu2026,
author = {Xu, Mingying and Zhang, Wanyi},
title = {Spectral Metafiction as Différance of Authoritative Narrative in Alias Grace},
journal = {International Journal of English Literature and Social Sciences},
year = {2026},
volume = {11},
number = {6},
pages = {149--160},
doi = {10.22161/ijels.116.20}
}
EUVIMED